Tianjin Chase Sun Pharmaceutical Co Ltd - Asset Resilience Ratio

Latest as of December 2023: -0.89%

Tianjin Chase Sun Pharmaceutical Co Ltd (300026) has an Asset Resilience Ratio of -0.89% as of December 2023. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read 300026 current and long-term liabilities for a breakdown of total debt and financial obligations.

Liquid Assets

CN¥-105.72 Million
≈ $-15.47 Million USD Cash + Short-term Investments

Total Assets

CN¥11.84 Billion
≈ $1.73 Billion USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (2006–2023)

This chart shows how Tianjin Chase Sun Pharmaceutical Co Ltd's Asset Resilience Ratio has changed over time. See Tianjin Chase Sun Pharmaceutical Co Ltd shareholders equity for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Tianjin Chase Sun Pharmaceutical Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 300026 stock market capitalisation.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents CN¥0.00 0%
Short-term Investments CN¥-105.72 Million -0.89%
Total Liquid Assets CN¥-105.72 Million -0.89%

Asset Resilience Insights

  • Limited Liquidity: Tianjin Chase Sun Pharmaceutical Co Ltd maintains only -0.89% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company primarily holds liquidity in cash and equivalents rather than short-term investments.

Tianjin Chase Sun Pharmaceutical Co Ltd Industry Peers by Asset Resilience Ratio

Compare Tianjin Chase Sun Pharmaceutical Co Ltd's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Daihan Pharmaceutical Co.Ltd
KQ:023910
Drug Manufacturers - Specialty & Generic 11.95%
Aurobindo Pharma Limited
NSE:AUROPHARMA
Drug Manufacturers - Specialty & Generic 16.92%
China Resources Sanjiu Medical & Pharmaceutical Co Ltd
SHE:000999
Drug Manufacturers - Specialty & Generic 5.22%
Ningbo Menovo Pharm Co Ltd
SHG:603538
Drug Manufacturers - Specialty & Generic 2.69%
Zhejiang Xianju Pharmaceutical Co Ltd
SHE:002332
Drug Manufacturers - Specialty & Generic 6.02%
Qianjiang Yongan Pharmaceutical Co Ltd
SHE:002365
Drug Manufacturers - Specialty & Generic 30.38%
Hainan Honz Pharmaceutical Co
SHE:300086
Drug Manufacturers - Specialty & Generic 0.27%
Guangdong Lifestrong Pharmacy Co. Ltd.
SHE:301111
Drug Manufacturers - Specialty & Generic 7.85%

Annual Asset Resilience Ratio for Tianjin Chase Sun Pharmaceutical Co Ltd (2006–2023)

The table below shows the annual Asset Resilience Ratio data for Tianjin Chase Sun Pharmaceutical Co Ltd.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2023-12-31 -0.89% CN¥-105.72 Million
≈ $-15.47 Million
CN¥11.84 Billion
≈ $1.73 Billion
+0.36pp
2022-12-31 -1.25% CN¥-158.00 Million
≈ $-23.12 Million
CN¥12.63 Billion
≈ $1.85 Billion
+0.33pp
2021-12-31 -1.58% CN¥-183.67 Million
≈ $-26.88 Million
CN¥11.61 Billion
≈ $1.70 Billion
+0.20pp
2020-12-31 -1.78% CN¥-181.52 Million
≈ $-26.56 Million
CN¥10.18 Billion
≈ $1.49 Billion
-1.09pp
2019-12-31 -0.69% CN¥-58.31 Million
≈ $-8.53 Million
CN¥8.43 Billion
≈ $1.23 Billion
-0.28pp
2018-12-31 -0.41% CN¥-30.99 Million
≈ $-4.53 Million
CN¥7.48 Billion
≈ $1.10 Billion
-0.53pp
2006-12-31 0.12% CN¥124.36K
≈ $18.20K
CN¥105.62 Million
≈ $15.46 Million
--
pp = percentage points

About Tianjin Chase Sun Pharmaceutical Co Ltd

SHE:300026 China Drug Manufacturers - Specialty & Generic
Market Cap
$1.50 Billion
CN¥10.27 Billion CNY
Market Cap Rank
#7372 Global
#1758 in China
Share Price
CN¥3.42
Change (1 day)
-0.29%
52-Week Range
CN¥3.24 - CN¥4.33
All Time High
CN¥9.11
About

Tianjin Chase Sun Pharmaceutical Co.,Ltd engages in the research and development, production, and sale of various pharmaceutical products in China and internationally. The company provides Chinese medicine formula granules, finished drugs, raw materials, medical devices and excipients, medical and health services, as well as smart supply chain for pharmaceuticals and medical devices. It serves th… Read more